Prior to PSA screening, DRE was the fundamental method of prostate cancer screening; however, by the 1990s, both PSA and DRE were used in conjunction for screening as DRE alone was deemed ineffective to detect prostate cancer [45]. This evidence concerns the gene KLK3 and Familial prostate cancer.